Lifestyle and diet as risk factors for overanticoagulation

Journal of Clinical Epidemiology

Volumn 55, Issue 4, 2002, Pages 411-417

  Penning van Beest, Fernie J A ^a   Geleijnse, Johanna M ^b   Van Meegen, Erik ^c   Vermeer, Cees ^d   Rosendaal, Frits R ^e   Stricker, Bruno H C ^a,f  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c Red Cross Hospital Den Haag   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Drug Safety Unit   (Netherlands)

Author keywords

Case control study; Coumarin anticoagulants; Diet; Lifestyle; Overanticoagulation; Risk factors

Indexed keywords

COUMARIN ANTICOAGULANT; CYTOCHROME P450; FARNOQUINONE; PHYTOMENADIONE; VITAMIN K GROUP;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLEEDING; CASE CONTROL STUDY; DIET; DRUG TOXICITY; EDUCATION; FEMALE; HUMAN; INTERVIEW; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; RISK FACTOR; WEIGHT REDUCTION;

AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ANTICOAGULANTS; BODY MASS INDEX; CASE-CONTROL STUDIES; COUMARINS; FEMALE; FOOD HABITS; FOOD-DRUG INTERACTIONS; HUMANS; INTERNATIONAL NORMALIZED RATIO; LIFE STYLE; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0036126833     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(01)00485-1     Document Type: Article

References (35)

1. Guidelines on oral anticoagulation; third edition
2. Structure and mechanism of activation of vitamin K antagonists
3. The Scylla and Charybdis of oral anticoagulant treatment
4. Optimal oral anticoagulant therapy in patients with mechanical heart valves
5. Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants
6. Aging and the anticoagulant response to warfarin therapy
7. Effect of weight loss on coagulation factors VII and X
8. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors
9. Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly; the Cardiovascular Health Study
10. Clinical and toxicological consequences of the inductive potential of ethanol
11. Drug interactions with tobacco smoking; an update
12. Effect of stress on drug hypersensitivity
13. Dietary modification as cause of anticoagulation instability
14. Anticoagulation instability with life-threatening complication after dietary modification
15. Interaction of dietary factors with oral anticoagulants; review and applications
16. Optimal therapeutic anticoagulation
17. Laboratory control, optimal therapeutic ranges and therapeutic quality control in oral anticoagulation
18. Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer
19. Dietary assessment in the elderly; validation of a semiquantitative food frequency questionnaire
20. Effect of food composition on vitamin K absorption in human volunteers
21. Chemistry, nutritional sources, tissue distribution and metabolism of vitamin K with special reference to bone health
22. Vitamin K and human nutrition
23. Vitamin K
24. Development of a diet low in vitamin K-1 (phylloquinone)
25. Vitamin K-1 (phylloquinone) content of foods; a provisional table
26. Tea and coffee brews are not dietary sources of vitamin K-1 (phylloquinone)
27. Effects of vitamin K on bone mass and bone metabolism
28. 2 (menaquinone) in the Netherlands
29. Clinically important drug interactions with anticoagulants. An update
30. Oral anticoagulants; mechanism of action, clinical effectiveness, and optimal therapeutic range
31. Drugs affecting blood clotting, fibrinolysis, and hemostasis
32. Drug interactions with warfarin
33. Acetaminophen and other risk factors for excessive warfarin anticoagulation